Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.7 USD | +0.75% | -6.25% | -6.57% |
Feb. 12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Feb. 07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.57% | 25.19M | |
+35.66% | 664B | |
+29.71% | 567B | |
-7.19% | 354B | |
+19.64% | 330B | |
+4.56% | 286B | |
+13.57% | 234B | |
+5.35% | 199B | |
-9.90% | 196B | |
-4.72% | 148B |
- Stock Market
- Equities
- ACST Stock
- News Acasti Pharma Inc.
- Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target